RE: RNS8 Aug 2025 14:25
You don't know what my holding is in any company, so don't start guessing.
And re 201, tell me this - do you think a drug that was fushed out of a bin over a decade ago, tested on less than a dozen patients in a clinic in Georgia at the speed of a slug, half if whom failed to respond and the rest gave dubious responses, and has then sat without so much as a peer review for almost 6 years is ever going to do anything, let alone make money? If you read the last 201 about the 'results' you'll see it says 'Until regulatory approval has been reached and all the trial data verified, limited preliminary observations can be inferred.'
The only thing they could be sure of was that while the patients all died, 201 wasn't a contributing factor. It has a good safety profile, but then so does water.